Clinical Trial Update: A Two Arm Trial of Axitinib and Carboplatin/Paclitaxel in Melanoma [Phase 2]

View source ↗

Summary

Phase 2 two-arm trial of axitinib in combination with carboplatin/paclitaxel in melanoma has completed, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Axitinib (Inlyta) (Axitinib)
• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Adil Daud | Conditions: Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2018-06-08